EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Hierarchical Zeolitic Imidazolate Framework-8@Au Cluster Nanocarriers for In Situ Chimeric Antigen Receptor Macrophage Programming and Immunotherapy in Prostate Cancer

Zichen Liang iD, Rui Wang, Yiyang Wang, Qing Wang, Yihan Chen, Zehui Zhang, Mengyuan He, Jiajie Yang, Luchen Sun, Qing Zhang, Hongqian Guo iD, Pingping Shen und 1 weitere

ACS Nano · 2026

DOI: 10.1021/acsnano.5c11870 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, 2026. Verfasst von Zichen Liang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, and State Key Laboratory of Pharmac…. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Zeolites, Receptors, Chimeric Antigen, Imidazoles. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Jiangsu Province, National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsZeolitesReceptors, Chimeric AntigenImidazolesGoldImmunotherapyMaleAnimalsHumansMiceCell Line, TumorMacrophagesDrug CarriersMetal-Organic Frameworks

Stichwörter der Autor:innen

T cell activationchimeric antigen receptor-macrophagein situ macrophage editingprostate cancertargeted deliverytumor microenvironmentzeolite imidazolate framework-8

Substanzen

ZeolitesReceptors, Chimeric AntigenImidazolesGoldDrug CarriersZIF-8 metal-organic frameworkMetal-Organic Frameworks

Autor:innen und Institutionen

  • Department of Urology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, and State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Na…
  • The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, China.
  • Department of Urology, Nanjing Drum Tower Hospital, Medical School of Nanjing University, Institute of Urology, Nanjing University, Nanjing, Jiangsu 210008, China.

ORCID-Profile: Zichen Liang, Hongqian Guo, Nanfei Yang

Förderung

  • Natural Science Foundation of Jiangsu Province
  • National Natural Science Foundation of China
  • Natural Science Foundation of Zhejiang Province
  • Pivotal Life Sciences Sponsorship Program

Zitieren

APA

Liang, Z., Wang, R., Wang, Y., Wang, Q., Chen, Y., Zhang, Z., He, M., Yang, J., Sun, L., Zhang, Q., Guo, H., Shen, P., & Yang, N. (2026). Hierarchical Zeolitic Imidazolate Framework-8@Au Cluster Nanocarriers for In Situ Chimeric Antigen Receptor Macrophage Programming and Immunotherapy in Prostate Cancer. ACS Nano. https://doi.org/10.1021/acsnano.5c11870

Vancouver

Liang Z, Wang R, Wang Y, Wang Q, Chen Y, Zhang Z, et al. Hierarchical Zeolitic Imidazolate Framework-8@Au Cluster Nanocarriers for In Situ Chimeric Antigen Receptor Macrophage Programming and Immunotherapy in Prostate Cancer. ACS Nano. 2026. doi:10.1021/acsnano.5c11870

BibTeX
@article{Liang2026,
  author = {Liang, Zichen and Wang, Rui and Wang, Yiyang and Wang, Qing and Chen, Yihan and Zhang, Zehui and He, Mengyuan and Yang, Jiajie and Sun, Luchen and Zhang, Qing and Guo, Hongqian and Shen, Pingping and Yang, Nanfei},
  title = {Hierarchical Zeolitic Imidazolate Framework-8@Au Cluster Nanocarriers for In Situ Chimeric Antigen Receptor Macrophage Programming and Immunotherapy in Prostate Cancer},
  journal = {ACS Nano},
  year = {2026},
  doi = {10.1021/acsnano.5c11870}
}
Kostenlos starten →